Two years ago, MASS convened the Citizens’ Reference Panel on Pharmacare in Canada. Over the course of 5 days, 35 randomly selected Canadians met in Ottawa to consider whether there are better models that can improve access to prescription drugs. This representative group of Canadians heard from a range of experts, examined different options, and, together, developed a clear set of recommendations for Canada's health ministers and policy makers. You can find their final report here.
Following the Reference Panel, Panelist Jean-Pierre Ste-Onge and Panel Chair Peter MacLeod shared the panel’s findings with the House of Commons Standing Committee on Health. You can view a video of their presentation here.
Since 2016, the conversation on pharmacare has continued. The Advisory Council on the Implementation of National Pharmacare is now leading consultation on how to implement affordable pharmacare for Canadians. The consultation is open to all Canadians until September 28, and can be found here.
Read more about the findings of the Citizens’ Reference Panel on Pharmacare in Canada below:
Panel calling for national pharmacare plan via iHeartRadio